Es gab 50 kürzliche Insider-Transaktionen für GeoVax Labs, Inc. (GOVX), darunter 49 Käufe und 0 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $2.42M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Mckee Kelly T. Jr., Mcnally Robert T, Chase Randal D. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — GOVX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-08-07 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
Informierter Kauf |
1,107 |
$0.67 |
$741.69 |
3,494 |
| 2025-06-05 |
Mcnally Robert T |
Director |
RSU-Zuteilung |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Chase Randal D |
Director |
RSU-Zuteilung |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Dodd David A |
President, CEO |
RSU-Zuteilung |
185,500 |
$2.48 |
$460.04K |
185,500 |
| 2025-06-05 |
Newman Mark J |
Chief Scientific Officer |
RSU-Zuteilung |
70,000 |
$2.48 |
$173.6K |
70,000 |
| 2025-06-05 |
Spencer John N Jr |
Director |
RSU-Zuteilung |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Reynolds Mark |
CFO |
RSU-Zuteilung |
70,000 |
$2.48 |
$173.6K |
70,000 |
| 2025-06-05 |
Kollintzas Dean G |
Director |
RSU-Zuteilung |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Sharkey John W. |
VP, Business Development |
RSU-Zuteilung |
70,000 |
$2.48 |
$173.6K |
70,000 |
| 2025-06-05 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
RSU-Zuteilung |
70,000 |
$2.48 |
$173.6K |
70,000 |
| 2025-06-05 |
Lemerond Nicole |
Director |
RSU-Zuteilung |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Morgan Jayne |
Director |
RSU-Zuteilung |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-04-10 |
Sharkey John W. |
VP, Business Development |
Informierter Kauf |
6,000 |
$0.99 |
$5.94K |
6,191 |
| 2025-04-10 |
Spencer John N Jr |
Director |
Informierter Kauf |
10,000 |
$0.98 |
$9.8K |
11,402 |
| 2025-04-01 |
Dodd David A |
President, CEO |
Informierter Kauf |
10,000 |
$1.08 |
$10.8K |
36,661 |
| 2025-03-31 |
Reynolds Mark |
CFO |
Informierter Kauf |
6,800 |
$1.08 |
$7.34K |
14,013 |
| 2024-08-12 |
Mcnally Robert T |
Director |
RSU-Zuteilung |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Chase Randal D |
Director |
RSU-Zuteilung |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Dodd David A |
President, CEO |
RSU-Zuteilung |
35,000 |
$2.17 |
$75.95K |
35,000 |
| 2024-08-12 |
Newman Mark J |
Chief Scientific Officer |
RSU-Zuteilung |
15,700 |
$2.17 |
$34.07K |
15,700 |
| 2024-08-12 |
Spencer John N Jr |
Director |
RSU-Zuteilung |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Reynolds Mark |
CFO |
RSU-Zuteilung |
15,700 |
$2.17 |
$34.07K |
15,700 |
| 2024-08-12 |
Kollintzas Dean G |
Director |
RSU-Zuteilung |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Sharkey John W. |
VP, Business Development |
RSU-Zuteilung |
15,700 |
$2.17 |
$34.07K |
15,700 |
| 2024-08-12 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
RSU-Zuteilung |
15,700 |
$2.17 |
$34.07K |
15,700 |
| 2024-08-12 |
Lemerond Nicole |
Director |
RSU-Zuteilung |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Morgan Jayne |
Director |
RSU-Zuteilung |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-09 |
Dodd David A |
President, CEO |
Informierter Kauf |
8,000 |
$1.95 |
$15.6K |
26,661 |
| 2024-02-22 |
Dodd David A |
President, CEO |
Informierter Kauf |
8,209 |
$2.27 |
$18.66K |
18,661 |
| 2024-02-21 |
Dodd David A |
President, CEO |
Informierter Kauf |
520 |
$2.15 |
$1.12K |
10,452 |
| 2024-02-07 |
Reynolds Mark |
CFO |
Informierter Kauf |
2,000 |
$2.77 |
$5.54K |
7,213 |
| 2023-12-22 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
Informierter Kauf |
6,944 |
$0.36 |
$2.5K |
35,782 |
| 2023-09-25 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
Informierter Kauf |
9,653 |
$0.52 |
$5.02K |
28,838 |
| 2023-08-25 |
Dodd David A |
President, CEO |
Informierter Kauf |
35,087 |
$0.57 |
$20K |
148,957 |
| 2023-08-18 |
Reynolds Mark |
CFO |
Informierter Kauf |
10,000 |
$0.52 |
$5.18K |
78,184 |
| 2023-08-01 |
Mcnally Robert T |
Director |
RSU-Zuteilung |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Chase Randal D |
Director |
RSU-Zuteilung |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Dodd David A |
President, CEO |
RSU-Zuteilung |
250,000 |
$0.76 |
$188.75K |
250,000 |
| 2023-08-01 |
Newman Mark J |
Chief Scientific Officer |
RSU-Zuteilung |
100,000 |
$0.76 |
$75.5K |
100,000 |
| 2023-08-01 |
Spencer John N Jr |
Director |
RSU-Zuteilung |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Reynolds Mark |
CFO |
RSU-Zuteilung |
100,000 |
$0.76 |
$75.5K |
100,000 |
| 2023-08-01 |
Kollintzas Dean G |
Director |
RSU-Zuteilung |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Sharkey John W. |
VP, Business Development |
RSU-Zuteilung |
100,000 |
$0.76 |
$75.5K |
100,000 |
| 2023-08-01 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
RSU-Zuteilung |
15,000 |
$0.76 |
$11.33K |
15,000 |
| 2023-08-01 |
Lemerond Nicole |
Director |
RSU-Zuteilung |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Morgan Jayne |
Director |
RSU-Zuteilung |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-04-24 |
Dodd David A |
President, CEO |
Informierter Kauf |
32,000 |
$0.64 |
$20.44K |
113,870 |
| 2023-04-20 |
Reynolds Mark |
CFO |
Informierter Kauf |
8,000 |
$0.63 |
$5.04K |
68,184 |
| 2022-12-07 |
Morgan Jayne |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-09-21 |
Chase Randal D |
Director |
Informierter Kauf |
10,000 |
$1.10 |
$11K |
36,613 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
